VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Metformin /day
Preclinical
Small molecule
A
Al-Rasheed University College
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Type 2 Diabetic Patients
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Type 2 Diabetic Patients
Preclinical
Completed
Clinical
Trials by Indication
[1]
Type 2 Diabetic Patients
1 trial
Pyridoxine Effect on the Blood Glucose Level in Type 2 Diabetic Patients
Completed
·
—
·
N/A
·
NCT05918068
·
108 enrolled
Metformin
1 trial
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
Completed
·
—
·
Phase 2
·
NCT05981742
·
75 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Metformin /day. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Metformin /day compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Metformin /day. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Al-Rasheed University College company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
A
Al-Rasheed University College
Related News